Mineral maturity and crystallinity index are distinct characteristics of bone mineral

The purpose of this study was to test the hypothesis that mineral maturity and crystallinity index are two different characteristics of bone mineral. To this end, Fourier transform infrared microspectroscopy (FTIRM) was used. To test our hypothesis, synthetic apatites and human bone samples were used for the validation of the two parameters using FTIRM. Iliac crest samples from seven human controls and two with skeletal fluorosis were analyzed at the bone structural unit (BSU) level by FTIRM on sections 2–4 lm thick. Mineral maturity and crystallinity index were highly correlated in synthetic apatites but poorly correlated in normal human bone. In skeletal fluorosis, crystallinity index was increased and maturity decreased, supporting the fact of separate measurement of these two parameters. Moreover, results obtained in fluorosis suggested that mineral characteristics can be modified independently of bone remodeling. In conclusion, mineral maturity and crystallinity index are two different parameters measured separately by FTIRM and offering new perspectives to assess bone mineral traits in osteoporosis

Evaluation of two interaction techniques for visualization of dynamic graphs

Several techniques for visualization of dynamic graphs are based on different spatial arrangements of a temporal sequence of node-link diagrams. Many studies in the literature have investigated the importance of maintaining the user's mental map across this temporal sequence, but usually each layout is considered as a static graph drawing and the effect of user interaction is disregarded. We conducted a task-based controlled experiment to assess the effectiveness of two basic interaction techniques: the adjustment of the layout stability and the highlighting of adjacent nodes and edges. We found that generally both interaction techniques increase accuracy, sometimes at the cost of longer completion times, and that the highlighting outclasses the stability adjustment for many tasks except the most complex ones.Comment: Appears in the Proceedings of the 24th International Symposium on Graph Drawing and Network Visualization (GD 2016

Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling

PK/PD integration data. (DOCX 7 kb

Structural Basis for GTP-Dependent Dimerization of Hydrogenase Maturation Factor HypB

Maturation of [NiFe]-hydrogenase requires the insertion of iron, cyanide and carbon monoxide, followed by nickel, to the catalytic core of the enzyme. Hydrogenase maturation factor HypB is a metal-binding GTPase that is essential for the nickel delivery to the hydrogenase. Here we report the crystal structure of Archeoglobus fulgidus HypB (AfHypB) in apo-form. We showed that AfHypB recognizes guanine nucleotide using Asp-194 on the G5 loop despite having a non-canonical NKxA G4-motif. Structural comparison with the GTPγS-bound Methanocaldococcus jannaschii HypB identifies conformational changes in the switch I region, which bring an invariant Asp-72 to form an intermolecular salt-bridge with another invariant residue Lys-148 upon GTP binding. Substitution of K148A abolished GTP-dependent dimerization of AfHypB, but had no significant effect on the guanine nucleotide binding and on the intrinsic GTPase activity. In vivo complementation study in Escherichia coli showed that the invariant lysine residue is required for in vivo maturation of hydrogenase. Taken together, our results suggest that GTP-dependent dimerization of HypB is essential for hydrogenase maturation. It is likely that a nickel ion is loaded to an extra metal binding site at the dimeric interface of GTP-bound HypB and transferred to the hydrogenase upon GTP hydrolysis

Carbon dioxide fluxes across the Sierra de Guadarrama, Spain

Understanding the spatial and temporal variation in soil respiration within small geographic areas is essential to accurately assess the carbon budget on a global scale. In this study, we investigated the factors controlling soil respiration in an altitudinal gradient in a southern Mediterranean mixed pine–oak forest ecosystem in the north face of the Sierra de Guadarrama in Spain. Soil respiration was measured in five Pinus sylvestris L. plots over a period of 1 year by means of a closed dynamic system (LI-COR 6400). Soil temperature and water content were measured at the same time as soil respiration. Other soil physico-chemical and microbiological properties were measured during the study. Measured soil respiration ranged from 6.8 to 1.4 lmol m-2 s-1, showing the highest values at plots situated at higher elevation. Q10 values ranged between 1.30 and 2.04, while R10 values ranged between 2.0 and 3.6. The results indicate that the seasonal variation of soil respiration was mainly controlled by soil temperature and moisture. Among sites, soil carbon and nitrogen stocks regulate soil respiration in addition to soil temperature and moisture. Our results suggest that application of standard models to estimate soil respiration for small geographic areas may not be adequate unless other factors are considered in addition to soil temperature

Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients

Background: Bladder cancer (BC) predominantly affects the elderly and is often the cause of death among patients with muscleinvasive disease. Clinicians lack quantitative estimates of competing mortality risks when considering treatments for BC. Our aim was to determine the bladder cancer-specific mortality (CSM) rate and other-cause mortality (OCM) rate for patients with newly diagnosed BC. Methods: Patients (n ¼ 3281) identified from a population-based cancer registry diagnosed between 1994 and 2009. Median follow-up was 48.15 months (IQ range 18.1–98.7). Competing risk analysis was performed within patient groups and outcomes compared using Gray’s test. Results: At 5 years after diagnosis, 1246 (40%) patients were dead: 617 (19%) from BC and 629 (19%) from other causes. The 5-year BC mortality rate varied between 1 and 59%, and OCM rate between 6 and 90%, depending primarily on the tumour type and patient age. Cancer-specific mortality was highest in the oldest patient groups. Few elderly patients received radical treatment for invasive cancer (52% vs 12% for patients o60 vs 480 years, respectively). Female patients with high-risk non-muscle-invasive BC had worse CSM than equivalent males (Gray’s Po0.01). Conclusion: Bladder CSM is highest among the elderly. Female patients with high-risk tumours are more likely to die of their disease compared with male patients. Clinicians should consider offering more aggressive treatment interventions among older patients

Early changes within the lymphocyte population are associated with the development of multiple organ dysfunction syndrome in trauma patients

2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.JM was funded, in part, by the Royal College of Surgeons of England, The Phillip King Charitable Trust Research Fellowship and The National Institute of Health Research (NIHR)

Detecting spatio-temporal mortality clusters of European countries by sex and ag

[EN] Background: Mortality decreased in European Union (EU) countries during the last century. Despite these similar trends, there are still considerable differences in the levels of mortality between Eastern and Western European countries. Sub-group analysis of mortality in Europe for different age and sex groups is common, however to our knowledge a spatio-temporal methodology as in this study has not been applied to detect significant spatial dependence and interaction with time. Thus, the objective of this paper is to quantify the dynamics of mortality in Europe and detect significant clusters of mortality between European countries, applying spatio-temporal methodology. In addition, the joint evolution between the mortality of European countries and their neighbours over time was studied. Methods: The spatio-temporal methodology used in this study takes into account two factors: time and the geographical location of countries and, consequently, the neighbourhood relationships between them. This methodology was applied to 26 European countries for the period 1990-2012. Results: Principally, for people older than 64 years two significant clusters were obtained: one of high mortality formed by Eastern European countries and the other of low mortality composed of Western countries. In contrast, for ages below or equal to 64 years only the significant cluster of high mortality formed by Eastern European countries was observed. In addition, the joint evolution between the 26 European countries and their neighbours during the period 1990-2012 was confirmed. For this reason, it can be said that mortality in EU not only depends on differences in the health systems, which are a subject to national discretion, but also on supra-national developments. Conclusions: This paper proposes statistical tools which provide a clear framework for the successful implementation of development public policies to help the UE meet the challenge of rethinking its social model (Social Security and health care) and make it sustainable in the medium term.The authors are grateful for the financial support provided by the Ministry of Economy and Competitiveness, project MTM2013-45381-P. Adina Iftimi gratefully acknowledges financial support from the MECyD (Ministerio de Educacion, Cultura y Deporte, Spain) Grant FPU12/04531. Francisco Montes is grateful for the financial support provided by the Spanish Ministry of Economy and Competitiveness, project MTM2016-78917-R. The research by Patricia Carracedo and Ana Debon has been supported by a grant from the Mapfre Foundation.Carracedo-Garnateo, P.; Debón Aucejo, AM.; Iftimi, A.; Montes-Suay, F. (2018). Detecting spatio-temporal mortality clusters of European countries by sex and ag. International Journal for Equity in Health. 17:1-19. https://doi.org/10.1186/s12939-018-0750-zS11917Anderson TW, Goodman LA. Statistical Inference about Markov Chains. Ann Math Stat. 1957; 28(1):89–110.Anselin L. Local Indicators of Spatial Association–LISA. Geographical Anal. 1995; 27(2):93–115.Bilbao-Ubillos J. Is there still such a thing as the ‘European social model’?. Int J Soc Welf. 2016; 25:110–25.Bivand R. spdep: Spatial Dependence:Weighting Schemes, Statistics and Models. 2012. R package version 0.5-53. http://CRAN.R-project.org/package=spdep .Bivand R, Hauke J, Kossowski T. Computing the Jacobian in Gaussian Spatial Autoregressive Models: An Illustrated Comparison of Available Methods. Geographical Anal. 2013; 45(2):150–79.Bivand R, Keitt T, Rowlingson B. rgdal: Bindings for the Geospatial Data Abstraction Library. 2016. R package version 1.1-10. https://CRAN.R-project.org/package=rgdal .Bivand R, Lewin-Koh N. maptools: Tools for Reading and Handling Spatial Objects. 2016. R package version 0.8-39 https://CRAN.R-project.org/package=maptools .Bonneux L, Huisman C. de Beer J. Mortality in 272 European regions, 2002-2004: an update. Eur J Epidemiol. 2010; 25(1):77–85. Reporting year: 2010.Charpentier A. Computational Actuarial Science with R. Chapman y Hall/CRC. 2014.Cliff AD, Ord JK. Spatial autocorrelation. London: Pion; 1973.Cutler D, Deaton A, Lleras-Muney A. The Determinants of Mortality. J Econ Perspect. 2006; 20(3):97–120.Debón A, Chaves L, Haberman S, Villa F. Characterization of between-group inequality of longevity in European Union countries. Insur Math Econ. 2017; 75:151–65.Fleiss J, Levin B, Paik M. Statistical Methods for Rates and Proportions: Wiley; 2013.Gordon M. Gmisc: Descriptive Statistics, Transition Plots, and More. 2016. R package version 1.3.1. https://CRAN.R-project.org/package=Gmisc .Hinde A. Demographic methods. Routledge: Routledge; 1998.Hyndman RJ, Booth H, Tickle L, Maindonald J. demography: Forecasting mortality, fertility, migration and population data. 2014. package version 1.18. https://CRAN.R-project.org/package=demography .Human Mortality Database. University of California, Berkeley (USA), and Max Planck Institute for Demographic Research (Germany). 2016. Available at www.mortality.org or www.humanmortality.de (data downloaded on 12th July 2016).Hatzopoulos P, Haberman S. Common mortality modeling and coherent forecasts. An empirical analysis of worldwide mortality data. Insurance Math Econ. 2013; 52(2):320–37.Iftimi A, Montes F, Santiyán AM, Martínez-Ruiz F. Space–time airborne disease mapping applied to detect specific behaviour of varicella in Valencia, Spain Spatial Spatio-Temporal Epidemiol. 2015; 14:33–44.Julious S, Nicholl J, George S. Why do we continue to use standardized mortality ratios for small area comparisons?. J Public Health. 2001; 23(1):40–6.Laurent T, Ruiz-Gazen A, Thomas-Agnan C. GeoXp: An R package for exploratory spatial data analysis. J Stat Softw. 2012; 47(2):1–23.Leon DA. Trends in European life expectancy: a salutary view. Int J Epidemiol. 2011; 40:271–7.Li H, Li L, Wu B, Xiong Y. The End of Cheap Chinese Labor. J Econ Perspect. 2013; 26(4):57–74.Mackenbach JP, Karanikolos M, McKee M. The unequal health of Europeans: successes and failures of policies. The Lancet. 2013; 381(9872):1125–34.Meslé F. Mortality in Central and Eastern Europe: Long-term trends and recent upturns. Demographic Res. 2004; 2:45–70.Meslé F, Vallin J. Mortality in Europe: The divergence between East and West. Population (English Edition). 2002; 57(1):157–97.Moran PAP. Notes on continuous stochastic phenomena. Biometrika. 1950; 37(1-2):17–23.Moran PAP. A Test for the Serial Independence of Residuals. Biometrika. 1950; 37(1/2):178–81.Neuwirth E. RColorBrewer: ColorBrewer Palettes. R package version. 2014; 1:1–2. https://CRAN.R-project.org/package=RColorBrewer .Oleckno WA. Epidemiology: concepts and methods: Waveland Press, Inc.; 2008.Quah D. Galton’s Fallacy and Tests of the Convergence Hypothesis. Scand J Econ. 1993; 95(4):427–43.R Core Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing. 2015. https://www.R-project.org/ .Rey S. In: Fischer MM, Nijkamp P, (eds).Spatial Dynamics and Space-Time Data Analysis. Berlin, Heidelberg: Springer: Handbook of Regional Science; 2014, pp. 1365–83.Rey SJ. Spatial Empirics for Economic Growth and Convergence. Geogr Anal. 2001; 33(3):195–214.Riffe T. Reading Human Fertility Database and Human Mortality Database data into R. Technical Report TR-2015-004, MPIDR. 2015.Schofield R, Reher D, Bideau A. The Decline of Mortality in Europe. International studies in demography. Oxford: Clarendon Press; 1991.Shaw M, Orford S, Brimblecombe N, Dorling D. Widening inequality in mortality between 160 regions of 15 European countries in the early 1990s. Soc Sci Med. 2000; 50(7-8):1047–58.Spinakis A, Anastasiou G, Panousis V, Spiliopoulos K, Palaiologou S, Yfantopoulos J. Expert Review and Proposals for Measurement of Health Inequalities in the European Union. European Commission. Technical report,Luxembourg: European Commission Directorate General for Health and Consumers; 2011. http://ec.europa.eu/health/social_determinants/docs/full_quantos_en.pdf .Staehr K. Economic transition in Estonia. Background, reforms and results In: Rindzeviciute E, editor. Contemporary Change in Estonia. Baltic and East European Studies. Sodertorns hogskola: Baltic and East European Studies: 2004. p. 437–67.Trnka L, Dankova D, Zitova J, Cimprichova L, Migliori GB, Clancy L, Zellweger J. Survey of BCG vaccination policy in Europe: 1994-96. Bull World Health Organ. 1998; 76(1):85–91.United Nations Inter–agency Group for Child Mortality Estimation. Levels & Trends in Child Mortality: Report 2013. New York: Technical report, United Nations Children’s Fund; 2013. Avaliable at www.who.int/maternal_child_adolescent/documents/levels_trends_child_mortality_2013.pdf Accessed 27 Oct 2016.Vågerö D. The east–west health divide in Europe: Growing and shifting eastwards. Eur Rev. 2010; 18(01):23–34.Vaupel JW, Zhang Z, van Raalte AA, Vaupel JW, Zhang Z, van Raalte AA. Life expectancy and disparity: an international comparison of life table data. BMJ Open. 2011; 1:e000128.Wickham H, Chang W. devtools: Tools to Make Developing R Packages Easier. R package version 1.11.1. 2016. https://CRAN.R-project.org/package=devtools .Wilcox R. Introduction to robust estimation and hypothesis testing, 3rd Edition.San Diego: Academic Press; 2012

The Pioneer Anomaly

Radio-metric Doppler tracking data received from the Pioneer 10 and 11 spacecraft from heliocentric distances of 20-70 AU has consistently indicated the presence of a small, anomalous, blue-shifted frequency drift uniformly changing with a rate of ~6 x 10^{-9} Hz/s. Ultimately, the drift was interpreted as a constant sunward deceleration of each particular spacecraft at the level of a_P = (8.74 +/- 1.33) x 10^{-10} m/s^2. This apparent violation of the Newton's gravitational inverse-square law has become known as the Pioneer anomaly; the nature of this anomaly remains unexplained. In this review, we summarize the current knowledge of the physical properties of the anomaly and the conditions that led to its detection and characterization. We review various mechanisms proposed to explain the anomaly and discuss the current state of efforts to determine its nature. A comprehensive new investigation of the anomalous behavior of the two Pioneers has begun recently. The new efforts rely on the much-extended set of radio-metric Doppler data for both spacecraft in conjunction with the newly available complete record of their telemetry files and a large archive of original project documentation. As the new study is yet to report its findings, this review provides the necessary background for the new results to appear in the near future. In particular, we provide a significant amount of information on the design, operations and behavior of the two Pioneers during their entire missions, including descriptions of various data formats and techniques used for their navigation and radio-science data analysis. As most of this information was recovered relatively recently, it was not used in the previous studies of the Pioneer anomaly, but it is critical for the new investigation.Comment: 165 pages, 40 figures, 16 tables; accepted for publication in Living Reviews in Relativit

Hemostatic powder TC-325 treatment of malignancy-related upper gastrointestinal bleeds: International registry outcomes

BACKGROUND AND AIM: Upper gastrointestinal tumors account for 5% of upper gastrointestinal bleeds. These patients are challenging to treat due to the diffuse nature of the neoplastic bleeding lesions, high rebleeding rates, and significant transfusion requirements. TC-325 (Cook Medical, North Carolina, USA) is a hemostatic powder for gastrointestinal bleeding. The aim of this study was to examine the outcomes of upper gastrointestinal bleeds secondary to tumors treated with Hemospray therapy. METHODS: Data were prospectively collected on the use of Hemospray from 17 centers. Hemospray was used during emergency endoscopy for upper gastrointestinal bleeds secondary to tumors at the discretion of the endoscopist as a monotherapy, dual therapy with standard hemostatic techniques, or rescue therapy. RESULTS: One hundred and five patients with upper gastrointestinal bleeds secondary to tumors were recruited. The median Blatchford score at baseline was 10 (interquartile range [IQR], 7-12). The median Rockall score was 8 (IQR, 7-9). Immediate hemostasis was achieved in 102/105 (97%) patients, 15% of patients had a 30-day rebleed, 20% of patients died within 30 days (all-cause mortality). There was a significant improvement in transfusion requirements following treatment (P < 0.001) when comparing the number of units transfused 3 weeks before and after treatment. The mean reduction was one unit per patient. CONCLUSIONS: Hemospray achieved high rates of immediate hemostasis, with comparable rebleed rates following treatment of tumor-related upper gastrointestinal bleeds. Hemospray helped in improving transfusion requirements in these patients. This allows for patient stabilization and bridges towards definitive surgery or radiotherapy to treat the underlying tumor